Accessed June 10, 2025
Table 3 summarizes the regional findings, including the direction of effects, medications used, administration duration, subject populations, and supporting studies
The regulator is also asking the drugmaker to carry out a clinical pharmacology trial using ultrasound to measure the effects of both temporary withholding of Foundayo and fasting duration on retained gastric contents, to see if it can lead to gastroparesis a potentially serious side effect that can lead to vomiting and entry of stomach contents into the airway
Consult your healthcare provider about alcohol and medication interactions
Obesity Management Medications are typically selected based on individual health factors, previous treatment attempts, and overall risk profile
To view digital features for this article go to Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are successfully used in the treatment of type 2 diabetes mellitus, improving glycaemic control with low risk of hypoglycaemia and inducing weight loss [1, 2]